Analysis of the targets affected by the miRNAs with no previous relation with breast cancer included in our signature, also identified several cancer-related pathways, including KRAS, EGFR, MAPK, VEGF, ERBB, PTEN, FOS, AKT1, etc. (Table 6, table 8, figure S8). The gene discussed is FOS; the disease is breast cancer.